ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
S

Long-term Outcomes of Early CP CML Patients who Have Achieved CCyR but not MMR After 24 Months on Frontline Imatinib Therapy

By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Sung-Huyn Kim
By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Sung-Huyn Kim
18 views
January 2, 2019
Comments 0
Login to view comments. Click here to Login
Brief Oral Communications (Clinical)
08:29

The Technical Decline in the Rate of CML Treatment-free Remission in…

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

M. Delord

11 views
06:58

Patients’ Perspectives on the Definition of Cure in Chronic Myeloid …

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

G. George

15 views
08:10

Long-term Outcomes of Early CP CML Patients who Have Achieved CCyR b…

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

S. Kim

18 views
06:31

Prevalence and Outcomes of Uncommon BCR-ABL Fusion Transcripts in Pa…

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Q. Jiang

18 views
05:34

Cumulative Incidence of Treatment-free Remission (TFR) for Patients …

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

N. Shanmuganathan

14 views